L45I (p.Leu45Ile) variant of CDKN2A (Tumor suppressor ARF)

L45I (p.Leu45Ile) in CDKN2A (Tumor suppressor ARF) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Familial melanoma. The available variant effect predictions contribute to a CATVariant prioritization score of 0.33 / 1. The record also includes population frequency data, published literature, and structural context.

L45I (p.Leu45Ile) variant details